• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK SE & CO. KG EVITY 8 DR-T; PACEMAKER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK SE & CO. KG EVITY 8 DR-T; PACEMAKER Back to Search Results
Model Number 407146
Device Problems Impedance Problem (2950); No Pacing (3268)
Patient Problem Syncope/Fainting (4411)
Event Date 11/24/2022
Event Type  malfunction  
Event Description
Patient taken to er due to loss of consciousness where v pacing failure was confirmed.Device was explanted due to pacing failure and impedance issue.Should additional information be received, this file will be updated.
 
Manufacturer Narrative
Prior to the analysis of the device, the quality documents accompanying the manufacturing process for this pacemaker were re-investigated and all production steps were performed accordingly.Particularly the final acceptance test proved the device functions to be as specified.Upon receipt, the pacemaker was properly interrogated revealing the battery status ok.The devices memory content was evaluated.No anomalies were noted.Evaluation of provided follow-up data from november 24 / 25, 2022 documented loss of capture in the atrial as well as in the ventricular channel.Manually triggered impedance measurements were unsuccessful.Inspection of home monitoring data revealed a decrease of the current consumption since november 14, 2022 indicating a missing pacing functionality.Thus, the pacemaker was subjected to an extensive electrical analysis and the ability of the device to deliver therapies was verified.Thereby the clinical observation was confirmed, the pacing capability was not available.The impedance measurement test was unsuccessful, only old impedance measurement values were displayed on the programmer.During the further course of the analysis, the pacemaker was reset manually to potentially resume the pacing functionality and the device was re-tested.After reset the pacemaker was fully capable to deliver appropriate anti-bradycardia therapy.Furthermore, a review of the memory content did not show any peculiarities.An additional long-term pacing test was initiated.During the test, each pacing pulse was recorded.The evaluation of these pacing pulses documented regular device behavior.No intermittent or permanent loss of output was present.A stress test under different temperature environments was performed.The pacemaker functionality was as expected.In conclusion, the clinical observation was confirmed, however, the root cause was not determinable.In particular, after a manually triggered pacemaker reset the device proved to be fully functional.Based on the device behavior during analysis, a component damage of the pacemaker does not seem likely.Instead, external influences, like strong electromagnetic fields, could have possibly contributed to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVITY 8 DR-T
Type of Device
PACEMAKER
Manufacturer (Section D)
BIOTRONIK SE & CO. KG
woermannkehre 1
berlin 12359
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key15877088
MDR Text Key304449954
Report Number1028232-2022-06010
Device Sequence Number1
Product Code NVZ
Combination Product (y/n)N
PMA/PMN Number
P950037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2020
Device Model Number407146
Device Catalogue NumberSEE MODEL NO.
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/25/2022
Initial Date FDA Received11/29/2022
Supplement Dates Manufacturer Received01/25/2023
Supplement Dates FDA Received01/25/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/21/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-